COMMUNIQUÉS West-GlobeNewswire

Sorrento Therapeutics Announces Unsecured $120.5M Convertible Note Financing

27/03/2018 - 14:00

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it has entered into a securities purchase agreement to sell $120.5 million of unsecured [...]

Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad

27/03/2018 - 13:30

MENLO PARK, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio ® [...]

NexImmune Announces Management and Board Appointments

27/03/2018 - 13:30

Scott Carmer appointed Chief Executive Officer Kristi Jones promoted to Chief Operating Officer Alan Roemer appointed Chairman of the Board of Directors GAITHERSBURG, Md., March 27, 2018 (GLOBE NEWSWIRE) -- NexImmune, [...]

Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution

27/03/2018 - 13:05

PETALUMA, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the [...]

Immunovaccine Announces Webcast of R&D Update and Investor Event

27/03/2018 - 13:05

HALIFAX, Nova Scotia, March 27, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced today that it will webcast its ‘R&D Update and Investor [...]

Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution

27/03/2018 - 13:05

RALEIGH, N.C. , March 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, today announced that the company is a founding member of Align [...]

genedrive signs distribution agreement for India with ARKRAY Healthcare pvt Ltd for Genedrive® HCV ID Kit and Genedrive® platform

27/03/2018 - 13:01

For release: 27 March The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication [...]

Recro Pharma Announces Publication of Phase III IV Meloxicam Bunionectomy Data in the Clinical Journal of Pain

27/03/2018 - 13:00

MALVERN, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

Axsome Therapeutics to Host R&D Day with Key Opinion Leaders Focused on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine Dependence

27/03/2018 - 13:00

NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders [...]

Antares Pharma Provides XYOSTED™ Regulatory Update

27/03/2018 - 13:00

EWING, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that the official minutes from the Type A meeting with the U.S. Food and Drug Administration (FDA or the [...]

Summit Therapeutics Announces Placement of £15.0 Million of Ordinary Shares

27/03/2018 - 13:00

OXFORD, United Kingdom, March 27, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. [...]

Prospectus relating to Active Biotech's rights issue published

27/03/2018 - 09:40

2018-03-27 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD [...]

Summit Therapeutics Announces a Proposed Placing to Raise up to £15 Million

27/03/2018 - 08:01

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO MIGHT [...]

Tecan publishes 2017 Annual Report and notice of its Annual General Meeting

27/03/2018 - 07:31

Männedorf, Switzerland, March 27, 2018 - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2017 Annual Report in the Investor Relations section of the company's website at www.tecan.com [...]

Novartis to sell stake in consumer healthcare joint venture to GSK for USD13.0 billion to focus on strategic priorities

27/03/2018 - 07:01

Price reflects an attractive value to Novartis Proceeds to be used according to capital allocation priorities, including bolt-on acquisitions Sale of JV in a non-core segment in best long-term interests of Novartis [...]

Probiodrug AG to Publish its Full Year 2017 Results on 3 April 2018

27/03/2018 - 07:00

Probiodrug AG to Publish its Full Year 2017 Results on 3 April 2018 HALLE (SAALE), Germany, 27 March 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel [...]

VIFOR PHARMA CONCLUDES LICENSING AGREEMENT WITH ZERIA TO MARKET VELTASSA® IN JAPAN

27/03/2018 - 06:57

Vifor Pharma gives Zeria exclusive rights to develop and market Veltassa ® in Japan Potential of Veltassa ® further validated with expansion into Japanese market Deal expands cardio-renal network with Vifor Pharma's [...]

Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

27/03/2018 - 03:00

SINGAPORE, March 26, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]

Hua Medicine Raises $117.4 Million in Series D & Series E Financing

27/03/2018 - 02:00

HONG KONG and SHANGHAI, China, March 26, 2018 (GLOBE NEWSWIRE) -- Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes, announced the closing of a [...]